DRUG REGIMEN FOR TREATMENT OF CEREBRAL ISCHEMIA |
|||||||
| 申请号 | US15859075 | 申请日 | 2017-12-29 | 公开(公告)号 | US20180185475A1 | 公开(公告)日 | 2018-07-05 |
| 申请人 | Shimojani, LLC; | 发明人 | Lawrence M. KAUVAR; Damir JANIGRO; | ||||
| 摘要 | Treatment of subjects experiencing cerebral ischemia is improved when the treatment employs a thrombolytic and an inhibitor against vascular endothelial growth factor receptor signal transduction (VEGF-RST) at a reduced, low dosage compared to that used to treat cancer patients. The treatment is also improved to permit point-of-care use by formulating protein drugs for long term stability at room temperature, providing doses appropriate for the method, and by combining the therapeutic agents with a point-of-care diagnostic for blood brain barrier integrity. | ||||||
| 权利要求 | |||||||
| 说明书全文 | |||||||
QQ群二维码
意见反馈
意见反馈